Join
Live feed
·
FDARegulatoryvia Quantisnow
Celgene Corporation logo

March 27, 2021 - FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma

ByQuantisnow·Wall Street's wire, on your screen.
CELG~· Celgene Corporation
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELG~ (Celgene Corporation) and more on Quantisnow.